Paper39447490
Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease.
Lu W and 10 others. Neurobiol Aging, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease. Papers, record 39447490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39447490
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Disease Models, Animal | Major topic |
| Amyloid beta-Peptides | Major topic |
| Mice, Transgenic | Major topic |
| Amyloid beta-Protein Precursor | Major topic |
| Animals | |
| Female | |
| Male | |
| Plaque, Amyloid | |
| Mice | |
| Humans | |
| Brain | |
| Cognition Disorders | |
| Mutation | |
| Homozygote |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG078615 | NIA NIH HHS | United States | R01AG078615 | PubMed and NIH | NIH RePORTER |
| R21 AG065653 | NIA NIH HHS | United States | R21AG065653 | PubMed and NIH | NIH RePORTER |
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27377630 | Cognitive deficits in single App knock-in mouse models. | Neurobiol Learn Mem | 2016 | https://conductscience.org/library/papers/27377630 | PubMed |
| 2 | 37991017 | Mitochondria-sequestered Aβ renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease. | JCI Insight | 2023 | https://conductscience.org/library/papers/37991017 | PubMed |
| 3 | 32024798 | APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid. | Sci Transl Med | 2020 | https://conductscience.org/library/papers/32024798 | PubMed |
| 4 | 34586832 | APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/34586832 | PubMed |
| 5 | 1302033 | A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. | Nat Genet | 1992 | https://conductscience.org/library/papers/1302033 | PubMed |
| 6 | 28768718 | APP mouse models for Alzheimer's disease preclinical studies. | EMBO J | 2017 | https://conductscience.org/library/papers/28768718 | PubMed |
| 7 | 32170138 | Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease. | Nat Commun | 2020 | https://conductscience.org/library/papers/32170138 | PubMed |
| 8 | 24728269 | Single App knock-in mouse models of Alzheimer's disease. | Nat Neurosci | 2014 | https://conductscience.org/library/papers/24728269 | PubMed |
| 9 | 11063718 | Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease. | Hum Mol Genet | 2000 | https://conductscience.org/library/papers/11063718 | PubMed |
| 10 | 20818335 | Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio. | EMBO J | 2010 | https://conductscience.org/library/papers/20818335 | PubMed |
| 11 | 35690868 | Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. | Mol Neurodegener | 2022 | https://conductscience.org/library/papers/35690868 | PubMed |
| 12 | 18694930 | The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18694930 | PubMed |
| 13 | 29985474 | Sex differences in Alzheimer disease - the gateway to precision medicine. | Nat Rev Neurol | 2018 | https://conductscience.org/library/papers/29985474 | PubMed |
| 14 | 37545238 | Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology. | J Alzheimers Dis | 2023 | https://conductscience.org/library/papers/37545238 | PubMed |
| 15 | 24650793 | Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. | Neurobiol Aging | 2014 | https://conductscience.org/library/papers/24650793 | PubMed |
| 16 | 17046788 | Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity. | J Mol Biol | 2006 | https://conductscience.org/library/papers/17046788 | PubMed |
| 17 | 34366832 | Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study. | Front Aging Neurosci | 2021 | https://conductscience.org/library/papers/34366832 | PubMed |
| 18 | 30980041 | Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta. | Mol Psychiatry | 2020 | https://conductscience.org/library/papers/30980041 | PubMed |
| 19 | 11528419 | The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. | Nat Neurosci | 2001 | https://conductscience.org/library/papers/11528419 | PubMed |
| 20 | 30250265 | Animal models of neurodegenerative diseases. | Nat Neurosci | 2018 | https://conductscience.org/library/papers/30250265 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42664049 | Metabolic Shifts Precede Cognitive Decline in the Male hAß-KI Alzheimer's Mouse Model. | FASEB J | 2026 | https://conductscience.org/library/papers/42664049 | PubMed |
| 41913059 | Glial cytokine modulation improves sleep and circadian disruption in female SAA knock-in mice of Alzheimer's-related pathology. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/41913059 | PubMed |
| 41717780 | Dim light at night impacts circadian rhythms and Alzheimer's disease-like neuroinflammation and neuropathology in humanized APP SAA knock-in mice. | Sleep | 2026 | https://conductscience.org/library/papers/41717780 | PubMed |
| 41256678 | Dim light at night impacts circadian rhythms and Alzheimer's disease-like neuroinflammation and neuropathology in humanized APP SAA knock-in mice. | bioRxiv | 2025 | https://conductscience.org/library/papers/41256678 | PubMed |
| 41000956 | Characterization of adult hippocampal neurogenesis in the novel App SAA Knock-in Alzheimer's disease mouse model. | bioRxiv | 2025 | https://conductscience.org/library/papers/41000956 | PubMed |
| 39920176 | Longitudinal characterization reveals behavioral impairments in aged APP knock in mouse models. | Sci Rep | 2025 | https://conductscience.org/library/papers/39920176 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39447490
GET https://conductscience.org/api/papers/v1/39447490/references?page=2